Market closed
Zynex/$ZYXI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Zynex
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
Ticker
$ZYXI
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
1,000
Website
Zynex Metrics
BasicAdvanced
$73M
26.78
$0.09
0.81
-
Price and volume
Market cap
$73M
Beta
0.81
52-week high
$11.50
52-week low
$1.93
Average daily volume
279K
Financial strength
Current ratio
4.458
Quick ratio
3.419
Long term debt to equity
194.654
Total debt to equity
206.744
Dividend payout ratio (TTM)
0.30%
Interest coverage (TTM)
2.51%
Management effectiveness
Return on assets (TTM)
2.89%
Return on equity (TTM)
7.32%
Valuation
Price to earnings (TTM)
26.778
Price to revenue (TTM)
0.4
Price to book
2.15
Price to tangible book (TTM)
9.53
Price to free cash flow (TTM)
6.339
Growth
Revenue change (TTM)
4.36%
Earnings per share change (TTM)
-66.67%
3-year revenue growth (CAGR)
13.86%
3-year earnings per share growth (CAGR)
-41.08%
What the Analysts think about Zynex
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Zynex stock.
Zynex Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Zynex Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Zynex News
AllArticlesVideos
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Zynex, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ZYXI
GlobeNewsWire·18 hours ago
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zynex
GlobeNewsWire·20 hours ago
Shareholders of Zynex, Inc. Should Contact Levi & Korsinsky Before May 19, 2025 to Discuss Your Rights - ZYXI
Accesswire·2 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Zynex stock?
Zynex (ZYXI) has a market cap of $73M as of April 27, 2025.
What is the P/E ratio for Zynex stock?
The price to earnings (P/E) ratio for Zynex (ZYXI) stock is 26.78 as of April 27, 2025.
Does Zynex stock pay dividends?
No, Zynex (ZYXI) stock does not pay dividends to its shareholders as of April 27, 2025.
When is the next Zynex dividend payment date?
Zynex (ZYXI) stock does not pay dividends to its shareholders.
What is the beta indicator for Zynex?
Zynex (ZYXI) has a beta rating of 0.81. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.